Abstract
Purpose of Review
CTO revascularization has been a topic of ongoing debate because of its high technical complexity and expected benefits. This review focuses on describing the various strategies for CTO revascularization, associated complications, and their outcomes.
Recent Findings
The hybrid algorithm is the most widely used method for CTO revascularization. The various strategies for CTO crossing are as follows: antegrade wire escalation (AWE), antegrade dissection/re-entry (ADR), and retrograde approach. DECISION-CTO, EURO-CTO, and EXPLORE are the three large randomized trials that studied the impact of complete revascularization with CTO-PCI and conclude that successful CTO-PCI is non-inferior to medical therapy.
Summary
CTO revascularization is a very challenging and complex procedure with a higher risk of complications compared to non-CTO revascularization. With the development of techniques like hybrid algorithm, use of specialized guide wires, drug-eluting stents with low risk of in-stent restenosis, and increased training of operators with increasing procedural volumes, the overall benefits of CTO-PCI revascularization are higher than the complications. CTO-PCI not only can improve overall mortality and survival but also improves angina, reduces burden of ventricular arrhythmia, and reduces the need for subsequent CABG.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Yang JH, Kim BS, Jang WJ, Ahn J, Park TK, Song YB, et al. Optimal medical therapy vs. percutaneous coronary intervention for patients with coronary chronic total occlusion - a propensity-matched analysis. Circ J. 2016;80(1):211–7. https://doi.org/10.1253/circj.CJ-15-0673.
Fefer P, Knudtson ML, Cheema AN, Galbraith PD, Osherov AB, Yalonetsky S, et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol. 2012;59(11):991–7. https://doi.org/10.1016/j.jacc.2011.12.007.
Alessandrino G, Chevalier B, Lefevre T, Sanguineti F, Garot P, Unterseeh T, et al. A clinical and angiographic scoring system to predict the probability of successful first-attempt percutaneous coronary intervention in patients with total chronic coronary occlusion. JACC Cardiovasc Interv. 2015;8(12):1540–8. https://doi.org/10.1016/j.jcin.2015.07.009.
Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, et al. The hybrid approach to chronic total occlusion percutaneous coronary intervention: update from the PROGRESS CTO registry. JACC Cardiovasc Interv. 2018;11(14):1325–35. https://doi.org/10.1016/j.jcin.2018.02.036.
Joyal D, Afilalo J, Rinfret S. Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis. Am Heart J. 2010;160(1):179–87. https://doi.org/10.1016/j.ahj.2010.04.015.
Azzalini L, Jolicoeur EM, Pighi M, Millan X, Picard F, Tadros VX, et al. Epidemiology, management strategies, and outcomes of patients with chronic total coronary occlusion. Am J Cardiol. 2016;118(8):1128–35. https://doi.org/10.1016/j.amjcard.2016.07.023.
Morino Y, Abe M, Morimoto T, Kimura T, Hayashi Y, Muramatsu T, et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (multicenter CTO registry in Japan) score as a difficulty grading and time assessment tool. JACC Cardiovasc Interv. 2011;4(2):213–21. https://doi.org/10.1016/j.jcin.2010.09.024.
• Wilson WM, Walsh SJ, Yan AT, Hanratty CG, Bagnall AJ, Egred M, et al. Hybrid approach improves success of chronic total occlusion angioplasty. Heart. 2016;102(18):1486–93. https://doi.org/10.1136/heartjnl-2015-308891This reference explains hybrid algorithm which describes the approach for crossing CTO lesions. Implementation of hybrid algorithm has significantly improved the success rates of CTO-PCI.
Christakopoulos GE, Christopoulos G, Carlino M, Jeroudi OM, Roesle M, Rangan BV, et al. Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. Am J Cardiol. 2015;115(10):1367–75. https://doi.org/10.1016/j.amjcard.2015.02.038.
Lee SW, Lee PH, Ahn JM, Park DW, Yun SC, Han S, et al. Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion. Circulation. 2019;139(14):1674–83. https://doi.org/10.1161/circulationaha.118.031313.
Brilakis ES, Grantham JA, Rinfret S, Wyman RM, Burke MN, Karmpaliotis D, et al. A percutaneous treatment algorithm for crossing coronary chronic total occlusions. JACC Cardiovasc Interv. 2012;5(4):367–79. https://doi.org/10.1016/j.jcin.2012.02.006.
Saeed B, Kandzari DE, Agostoni P, Lombardi WL, Rangan BV, Banerjee S, et al. Use of drug-eluting stents for chronic total occlusions: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2011;77(3):315–32. https://doi.org/10.1002/ccd.22690.
Sharma V, Wilson W, Smith W, McEntegart M, Oldroyd K, Sidik N, et al. Comparison of characteristics and complications in men versus women undergoing chronic total occlusion percutaneous intervention. Am J Cardiol. 2017;119(4):535–41. https://doi.org/10.1016/j.amjcard.2016.11.004.
Garcia S, Abdullah S, Banerjee S, Brilakis ES. Chronic total occlusions: patient selection and overview of advanced techniques. Curr Cardiol Rep. 2013;15(2):334. https://doi.org/10.1007/s11886-012-0334-2.
Lorenzo A, Enrico P, Mohamed A, Soledad O, Carlo Z, Alessio La M, et al. Coronary artery perforation during chronic total occlusion percutaneous coronary intervention: epidemiology, mechanisms, management, and outcomes. EuroIntervention. 2019;15(9):e804–e11.
Al-Lamee R, Ielasi A, Latib A, Godino C, Ferraro M, Mussardo M, et al. Incidence, predictors, management, immediate and long-term outcomes following grade III coronary perforation. J Am Coll Cardiol Intv. 2011;4(1):87–95.
Henriques JP, Hoebers LP, Ramunddal T, Laanmets P, Eriksen E, Bax M, et al. Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial. J Am Coll Cardiol. 2016;68(15):1622–32. https://doi.org/10.1016/j.jacc.2016.07.744.
•• Tajti P, Brilakis ES. Chronic total occlusion percutaneous coronary intervention: evidence and controversies. J Am Heart Assoc. 2018;7(2):e006732. https://doi.org/10.1161/JAHA.117.006732This article discusses three large randomized controlled trials which compare CTO-PCI to medical therapy in patients with coronary CTOs.
Valenti R, Migliorini A, Signorini U, Vergara R, Parodi G, Carrabba N, et al. Impact of complete revascularization with percutaneous coronary intervention on survival in patients with at least one chronic total occlusion. Eur Heart J. 2008;29(19):2336–42.
Khan MF, Wendel CS, Thai HM, Movahed MR. Effects of percutaneous revascularization of chronic total occlusions on clinical outcomes: a meta-analysis comparing successful versus failed percutaneous intervention for chronic total occlusion. Catheter Cardiovasc Interv. 2013;82(1):95–107.
Jang WJ, Yang JH, Choi S-H, Song YB, Hahn J-Y, Choi J-H, et al. Long-term survival benefit of revascularization compared with medical therapy in patients with coronary chronic total occlusion and well-developed collateral circulation. J Am Coll Cardiol Intv. 2015;8(2):271–9.
Yang ZK, Zhang RY, Hu J, Zhang Q, Ding FH, Shen WF. Impact of successful staged revascularization of a chronic total occlusion in the non-infarct-related artery on long-term outcome in patients with acute ST-segment elevation myocardial infarction. Int J Cardiol. 2013;165(1):76–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Shailee Shah, Jeffery Yourshaw, and Anbukarasi Maran declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Secondary Prevention and Intervention
Rights and permissions
About this article
Cite this article
Shah, S.Y., Yourshaw, J. & Maran, A. CTO Revascularization. Curr Cardiovasc Risk Rep 14, 25 (2020). https://doi.org/10.1007/s12170-020-00662-4
Accepted:
Published:
DOI: https://doi.org/10.1007/s12170-020-00662-4